C. Michael

The reversible epigenetic silencing of BRM: implications for clinical targeted therapy

D. Reisman, C. Muchardt, C. Kleer, 2007, Oncogene.

Survey of Activated FLT3 Signaling in Leukemia Please share how this access benefits you. Your story matters

S. Gygi, J. Kornhauser, J. Villén, 2011 .

CRISPR-based screen for Hedgehog signaling provides insights into function

Gaelen T. Hess, D. Breslow, D. Morgens, 2018 .